细胞治疗生物加工预计将从 2020 年的 111.925 亿美元增至 2028 年的 300.5261 亿美元。预计 2021-2028 年该市场将以 13.5% 的复合年增长率增长。
  ;
细胞治疗生物加工市场已根据技术、细胞类型、最终用户和地区进行了分析。按地区划分的市场分为北美、欧洲、亚太地区、中东和非洲、以及南美洲和中美洲。该报告强调市场趋势、技术进步、市场动态和领先公司竞争格局分析等参数,为细胞治疗生物加工市场提供见解和深入分析。它还包括对所有关键地区市场的 COVID-19 大流行的分析。
细胞治疗生物加工市场利润丰厚的区域市场洞察
细胞疗法获得越来越多的批准
细胞疗法通过提供再生药物和个性化药物,在治疗包括罕见遗传性疾病在内的各种慢性疾病方面显示出积极的效果。治疗慢性疾病的需求不断增长,推动了研发活动,导致细胞疗法生产和产品批准不断增长。下面列出了一些促进细胞治疗生物加工市场增长的细胞疗法批准实例。
- 2019 年 5 月,美国食品药品监督管理局 (FDA) 批准了诺华公司子公司 AveXis, Inc. 生产的 Zolgensma。 Zolgensa 旨在治疗两岁以下儿童脊髓性肌萎缩症,通过一次性静脉注射给药。
- 2020 年 7 月,吉利德公司子公司 Kite Pharma, Inc. 获得 FDA 批准批准其 Tecartus。 Tecartus 是一种 (CAR) T 细胞疗法,旨在治疗成人难治性套细胞淋巴瘤 (MCL)。据吉利德公司介绍,Tecartus是首个获批治疗套细胞淋巴瘤的(CAR)T细胞疗法,有望成为套细胞淋巴瘤治疗的新前沿。
- 2021年2月,Juno百时美施贵宝公司的子公司 Therapeutics, Inc. 的 Breyanzi 获得批准。 Breyanzi 是一种基于细胞的基因疗法,旨在治疗成人某些类型的大 B 细胞淋巴瘤。在患者对至少两种其他类型的全身治疗没有反应后进行治疗。然而,Breyanzi 在 2019 年自首次提交申请以来就面临监管挫折;它目前正在接受欧洲药品管理局的审查,并于 2020 年 7 月获得验证。
因此,不断增长的产品开发导致了各种产品的批准,这反映了细胞疗法的增长。因此,预计细胞疗法的批准不断增加将极大地增加细胞疗法生物加工,这反过来可能会推动未来几年市场的增长
基于技术的见解
细胞治疗生物加工市场按技术细分为生物反应器、冻干、静电纺丝、控制流离心、超声波裂解、基因组编辑技术、细胞永生化技术和病毒载体技术。生物反应器细分市场在 2020 年占据最大市场份额,而基因组编辑技术细分市场预计在预测期内复合年增长率最高,达到 14.5%。
细胞治疗生物加工市场,按技术划分– 2020年和2028年基于细胞类型的见解
细胞治疗生物加工市场按细胞类型分为干细胞、免疫细胞、人类胚胎干细胞细胞、多能干细胞、造血干细胞。干细胞细分市场在 2020 年占据最大的市场份额,而在预测期内,该细分市场预计复合年增长率最高,为 14.0%。
< p>基于最终用户的见解细胞治疗生物加工市场按适应症细分为心血管疾病 (CVD)、肿瘤学、伤口愈合、骨科等。肿瘤科领域在 2020 年占据最大的市场份额,骨科领域预计在预测期内复合年增长率最高,达到 14.3%。
战略见解
从事细胞治疗生物加工市场的公司正在采取有机战略,例如产品发布和扩张,以扩大其在全球的足迹和产品组合,并满足不断增长的需求。
按技术
- 生物反应器
- 冻干
- 静电纺丝
- 控制流离心
- 超声波裂解
- 基因组编辑技术
- 细胞永生化技术
- 病毒载体技术
按细胞类型划分
- 干细胞
- 免疫细胞
- 人胚胎干细胞
- 多能干细胞
- 造血干细胞
- li>
按适应症
- 心血管疾病(CVD)
- 肿瘤学
- 伤口愈合
- 骨科
- 其他
最终用户
- 医院和诊所
- 诊断中心 < li>再生医学中心
- 学术和研究所
按地理位置
- 北美
- 美国
- 加拿大
- 墨西哥
- 欧洲
- 法国
- 德国 < li>意大利
- 英国
- 西班牙
- 欧洲其他地区
- 南非
- 沙特阿拉伯
- 阿联酋
- 中东和非洲其他地区
- 巴西
- 阿根廷
- 其余骗局
公司简介
- Fresenius Kabi AG ;   ;
- 旭化成株式会社   ;
- 赛多利斯股份公司
- 默克两合公司
- 赛默飞世尔科技有限公司
- 康宁公司
- Cytiva   ;   ;
- 龙沙   ;   ;
- Repligen   ;   ;
- 康泰伦特公司
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Cell therapy bioprocessing is a subfield of bioprocess engineering that bridges cell therapy and bioprocessing (i.e., biopharmaceutical manufacturing). Cell therapy is one of the fastest-growing areas of the life sciences. It entails delivering entire living cells to a patient to treat disease.
Key factors driving the growth of the market are increasing investments for cell and gene therapy manufacturing, and growing approvals for cell therapies are the major factors driving the market growth. However, challenges such as high cost of product, regulatory challenges, and logistics challenges are likely to hinder the growth of the cell therapy bioprocessing market.
The costs of the Cell Therapy Bioprocessing are much higher, and they may cost US$ 50,000–100,000, or more, per cell therapy. The cost may also differ from product to product types.
The List of Companies - Cell Therapy Bioprocessing Market
- Fresenius Kabi AG
- Asahi Kasei Corporation
- Sartorius AG
- MERCK KGaA
- THERMO FISHER SCIENTIFIC INC.
- Corning Incorporated
- Cytiva
- Lonza
- Repligen
- Catalent Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Apr 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Apr 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Apr 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)